Compounds > n-methyl-3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Kidney Diseases

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Kidney Diseases in 6 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
" These toxic effects include hyperthermia, hypotonic hyponatremia due to its arginine vasopressin secretagogue-like effects, rhabdomyolysis, and cardiovascular collapse."2.50Nephrotoxic effects of common and emerging drugs of abuse. ( Herlitz, LC; Niles, JL; Pendergraft, WF; Rosner, M; Thornley-Brown, D, 2014)
"Besides smoking, alcohol abuse has also been implicated as a renal risk factor."2.41[Adverse renal effects of legal and illicit drugs]. ( Orth, SR, 2002)
"Her hyponatremia was slowly corrected."1.32Transient proximal tubular renal injury following Ecstasy ingestion. ( Dharnidharka, VR; Kwon, C; Zaritsky, A, 2003)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pendergraft, WF1
Herlitz, LC1
Thornley-Brown, D1
Rosner, M1
Niles, JL1
Campbell, GA1
Rosner, MH1
Kwon, C1
Zaritsky, A1
Dharnidharka, VR1
Yang, J1
Jamei, M1
Heydari, A1
Yeo, KR1
de la Torre, R1
Farré, M1
Tucker, GT1
Rostami-Hodjegan, A1
Woodrow, G1
Turney, JH1
Orth, SR1

Reviews

3 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Kidney Diseases

ArticleYear
Nephrotoxic effects of common and emerging drugs of abuse.
    Clinical journal of the American Society of Nephrology : CJASN, 2014, Nov-07, Volume: 9, Issue:11

    Topics: Anabolic Agents; Androgens; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cannabinoids

2014
The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Female; Hallucinogens; Humans; Hyponatremia; Kidney; Kidney Diseas

2008
[Adverse renal effects of legal and illicit drugs].
    Therapeutische Umschau. Revue therapeutique, 2002, Volume: 59, Issue:3

    Topics: Acute Kidney Injury; Adolescent; Adult; Alcoholism; Amphetamines; Anti-Anxiety Agents; Benzodiazepin

2002

Other Studies

3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Kidney Diseases

ArticleYear
Transient proximal tubular renal injury following Ecstasy ingestion.
    Pediatric nephrology (Berlin, Germany), 2003, Volume: 18, Issue:8

    Topics: Acute Disease; Adolescent; Female; Hallucinogens; Humans; Hyponatremia; Kidney Diseases; Kidney Tubu

2003
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6

    Topics: Algorithms; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2

2006
Ecstasy-induced renal vasculitis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:3

    Topics: Humans; Kidney Diseases; Male; N-Methyl-3,4-methylenedioxyamphetamine; Vasculitis

1999